Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938664 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
A Phase 2 study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01938664 is a Phase 2 study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 30 participants.
The verdict
NCT01938664, a Phase 2 study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a drug called Candesartan will help to reduce use of cocaine.
Interventions
- DRUG Candesartan with CBT
- OTHER Placebo with CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938664
The ClinicalTrials.gov registry entry for NCT01938664 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Candesartan with CBT is the first listed.
NCT01938664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938664 about?
NCT01938664 is a clinical study titled "A Pilot Study of Candesartan as a Treatment for Cocaine Dependence". The purpose of this study is to see if a drug called Candesartan will help to reduce use of cocaine.
What is the current status of trial NCT01938664?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2013-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01938664?
The interventions under investigation include: Candesartan with CBT (DRUG), Placebo with CBT (OTHER).
Who is sponsoring clinical trial NCT01938664?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.